MedPath

The risk of venous thrombosis during use of Qlaira (R).

Recruiting
Conditions
Veneuze trombose, venous thrombosis.Anticonceptie, contraception
Registration Number
NL-OMON21448
Lead Sponsor
MC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Competent women, 18-35 years with the wish to use an oral contraceptive (Qlaira or Microgynon-30).

Exclusion Criteria

1. People who are legally incapable;

2. Contra-indications for the use of oral contraceptives as described by the WHO and Dutch Society of Gynaecologists;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sex-Hormone Binding Globulin (SHBG) and Activated Protein C-resistance (APC-resistance).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath